[Federal Register: June 18, 2002 (Volume 67, Number 117)]
[Page 41432]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Protection of Human Subjects in Clinical Trials; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.


    The Food and Drug Administration (FDA) is announcing the following 
meeting: Protection of Human Subjects in Clinical Trials. The topics to 
be discussed are the role of FDA, institutional review boards, and 
other stakeholders in the protection of human subjects in clinical 
trials as it relates to minority participation.
    Date and Time: The meeting will be held on August 22, 2002, from 
7:30 p.m. to 9 p.m.
    Location: The meeting will be held at Meharry Medical School, West 
Basic Science Building Auditorium, rm. M001, 21st Avenue North at 
Meharry Blvd., Nashville, TN 37208.
    Contact: Sandra S. Baxter, Southeast Region, New Orleans District 
Office, Food and Drug Administration, 297 Plus Park Blvd., Nashville, 
TN 37217, 615-781-5385, ext. 122, FAX 615-781-5383, e-mail: 
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), and written material and requests to make oral 
presentations, to the contact person by August 8, 2002.
    If you need special accommodations due to a disability, please 
contact Sandra S. Baxter at least 7 days in advance.
    Transcripts: Transcripts of the meeting may be requested in writing 
from the Freedom of Information Office (HFI-35), Food and Drug 
Administration, 5600 Fishers Lane, rm. 12A-16, Rockville, MD 20857, 
approximately 15 working days after the meeting at a cost of 10 cents 
per page.

    Dated: June 10, 2002.
John Marzilli,
Acting Senior Associate Commissioner for Regulatory Affairs.
[FR Doc. 02-15279 Filed 6-17-02; 8:45 am]